Fundraising FoxPropel Bio Partners — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
LeonaBioleonabio.cominSep 2026 · $35M
LeonaBio develops novel therapeutics for treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS).
BiotechMedical Devices
Mark Litton(President and CEO)in
Co-investorsNew Enterprise Associates (NEA)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.